Skip to main content
Top
Published in: Pituitary 2/2019

01-04-2019 | Hypopituitarism

Pituitary incidentalomas in paediatric age are different from those described in adulthood

Authors: Pedro Souteiro, Rúben Maia, Rita Santos-Silva, Rita Figueiredo, Carla Costa, Sandra Belo, Cíntia Castro-Correia, Davide Carvalho, Manuel Fontoura

Published in: Pituitary | Issue 2/2019

Login to get access

Abstract

Purpose

Guidelines on pituitary incidentalomas evaluation and management are limited to adults since there are no data on this matter in the paediatric population. We aim to analyse the morphologic characteristics, hormonal profile and follow-up of these lesions in children.

Methods

We have searched for pituitary incidentalomas in the neuroimaging reports and electronic medical records of the Paediatric Endocrinology Clinic of our centre. Patients with 18 years-old or less were included.

Results

Forty-one incidentalomas were identified, 25 of them (62.4%) in females. The mean age at diagnosis was 12.0 ± 4.96 years-old. Headaches were the main reason that led to image acquisition (51.2%) and MRI was the imaging method that detected the majority of the incidentalomas (70.7%). The most prevalent lesion was pituitary hypertrophy (29.3%), which was mainly diagnosed in female adolescents (91.7%), followed by arachnoid cysts (17.1%), pituitary adenomas (14.6%) and Rathke’s cleft cysts (12.2%). Most patients (90.2%) did not present clinical or laboratorial findings of hypopituitarism or hormonal hypersecretion. Four patients presented endocrine dysfunction: three had growth hormone deficiency and one had a central precocious puberty. Twenty-three patients (56.1%) underwent imagiological revaluation during a median follow-up time of 24.6 months (interquartile range 5.07). None of them presented dimensional progression.

Conclusions

To the best of our knowledge, this is the first series of pituitary incidentalomas in pediatric age. Comparing our series with those conducted in adults, we have observed a higher preponderance of pituitary hypertrophy over adenomas, a lower prevalence of hormonal hyper/hyposecretion and lower risk of dimensional progression during follow-up.
Literature
1.
go back to reference Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML (2011) Pituitary incidentaloma: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96(4):894–904CrossRefPubMedPubMedCentral Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML (2011) Pituitary incidentaloma: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96(4):894–904CrossRefPubMedPubMedCentral
2.
3.
go back to reference Molitch ME (2009) Pituitary tumours: pituitary incidentalomas. Best practice & research. Clin Endocrinol Metab 23(5):667–675 Molitch ME (2009) Pituitary tumours: pituitary incidentalomas. Best practice & research. Clin Endocrinol Metab 23(5):667–675
4.
go back to reference Esteves C, Neves C, Augusto L, Menezes J, Pereira J, Bernardes I, Fonseca J, Carvalho D (2015) Pituitary incidentalomas: analysis of a neuroradiological cohort. Pituitary 18(6):777–781CrossRefPubMed Esteves C, Neves C, Augusto L, Menezes J, Pereira J, Bernardes I, Fonseca J, Carvalho D (2015) Pituitary incidentalomas: analysis of a neuroradiological cohort. Pituitary 18(6):777–781CrossRefPubMed
5.
go back to reference Sanno N, Oyama K, Tahara S, Teramoto A, Kato Y (2003) A survey of pituitary incidentaloma in Japan. Eur J Endocrinol 149(2):123–127CrossRefPubMed Sanno N, Oyama K, Tahara S, Teramoto A, Kato Y (2003) A survey of pituitary incidentaloma in Japan. Eur J Endocrinol 149(2):123–127CrossRefPubMed
6.
go back to reference Vaninetti NM, Clarke DB, Zwicker DA, Yip CE, Tugwell B, Doucette S, Theriault C, Aldahmani K, Imran SA (2018) A comparative, population-based analysis of pituitary incidentalomas vs clinically manifesting sellar masses. Endocr Connect 7(5):768–776CrossRefPubMedPubMedCentral Vaninetti NM, Clarke DB, Zwicker DA, Yip CE, Tugwell B, Doucette S, Theriault C, Aldahmani K, Imran SA (2018) A comparative, population-based analysis of pituitary incidentalomas vs clinically manifesting sellar masses. Endocr Connect 7(5):768–776CrossRefPubMedPubMedCentral
7.
go back to reference Goldberg AS, Stein R, Merritt NH, Inculet R, Van Uum S (2014) A pediatric patient with Cushing syndrome caused by ectopic ACTH syndrome and concomitant pituitary incidentalomas. J Pediatr Endocrinol Metab 27(1–2):123–128PubMed Goldberg AS, Stein R, Merritt NH, Inculet R, Van Uum S (2014) A pediatric patient with Cushing syndrome caused by ectopic ACTH syndrome and concomitant pituitary incidentalomas. J Pediatr Endocrinol Metab 27(1–2):123–128PubMed
9.
go back to reference Jagannathan J, Dumont AS, Jane JA Jr (2006) Diagnosis and management of pediatric sellar lesions. Front Horm Res 34:83–104CrossRefPubMed Jagannathan J, Dumont AS, Jane JA Jr (2006) Diagnosis and management of pediatric sellar lesions. Front Horm Res 34:83–104CrossRefPubMed
10.
go back to reference Kruis RWJ, Schouten-van Meeteren AYN, Finken MJJ, Oostdijk W, van Trotsenburg ASP, Boot AM, Claahsen-van der Grinten HL, van Lindert EJ, Han KS, Hoving EW, Michiels EMC, van Santen HM (2018) Management and consequences of postoperative fluctuations in plasma sodium concentration after pediatric brain tumor surgery in the sellar region: a national cohort analysis. Pituitary 21(4):384–392CrossRefPubMedPubMedCentral Kruis RWJ, Schouten-van Meeteren AYN, Finken MJJ, Oostdijk W, van Trotsenburg ASP, Boot AM, Claahsen-van der Grinten HL, van Lindert EJ, Han KS, Hoving EW, Michiels EMC, van Santen HM (2018) Management and consequences of postoperative fluctuations in plasma sodium concentration after pediatric brain tumor surgery in the sellar region: a national cohort analysis. Pituitary 21(4):384–392CrossRefPubMedPubMedCentral
11.
go back to reference Unsinn C, Neidert MC, Burkhardt JK, Holzmann D, Grotzer M, Bozinov O (2014) Sellar and parasellar lesions: clinical outcome in 61 children. Clin Neurol Neurosurg 123:102–108CrossRefPubMed Unsinn C, Neidert MC, Burkhardt JK, Holzmann D, Grotzer M, Bozinov O (2014) Sellar and parasellar lesions: clinical outcome in 61 children. Clin Neurol Neurosurg 123:102–108CrossRefPubMed
13.
go back to reference Barkovich A, Raybaud C (2012) Pediatric neuroimaging, 5th ed. Wolters Kluwer, Philadelphia Barkovich A, Raybaud C (2012) Pediatric neuroimaging, 5th ed. Wolters Kluwer, Philadelphia
14.
go back to reference Osborn A, Hedlung G, Salzman K (2017) Osborn’s brain: imaging, pathology, and anatomy, 2nd edn. Elsevier, Salt Lake City Osborn A, Hedlung G, Salzman K (2017) Osborn’s brain: imaging, pathology, and anatomy, 2nd edn. Elsevier, Salt Lake City
15.
go back to reference Imran SA, Yip CE, Papneja N, Aldahmani K, Mohammad S, Imran F, Zwicker DA, Theriault C, Thompson K, Clarke DB, Van Uum S (2016) Analysis and natural history of pituitary incidentalomas. Eur J Endocrinol 175(1):1–9CrossRefPubMed Imran SA, Yip CE, Papneja N, Aldahmani K, Mohammad S, Imran F, Zwicker DA, Theriault C, Thompson K, Clarke DB, Van Uum S (2016) Analysis and natural history of pituitary incidentalomas. Eur J Endocrinol 175(1):1–9CrossRefPubMed
16.
go back to reference Day PF, Guitelman M, Artese R, Fiszledjer L, Chervin A, Vitale NM, Stalldecker G, De Miguel V, Cornalo D, Alfieri A, Susana M, Gil M (2004) Retrospective multicentric study of pituitary incidentalomas. Pituitary 7(3):145–148CrossRefPubMed Day PF, Guitelman M, Artese R, Fiszledjer L, Chervin A, Vitale NM, Stalldecker G, De Miguel V, Cornalo D, Alfieri A, Susana M, Gil M (2004) Retrospective multicentric study of pituitary incidentalomas. Pituitary 7(3):145–148CrossRefPubMed
17.
go back to reference Anagnostis P, Adamidou F, Polyzos SA, Efstathiadou Z, Panagiotou A, Kita M (2011) Pituitary incidentalomas: a single-centre experience. Int J Clin Pract 65(2):172–177CrossRefPubMed Anagnostis P, Adamidou F, Polyzos SA, Efstathiadou Z, Panagiotou A, Kita M (2011) Pituitary incidentalomas: a single-centre experience. Int J Clin Pract 65(2):172–177CrossRefPubMed
18.
go back to reference Gondim JA, de Almeida JPC, de Albuquerque LAF, Schops M, Gomes É, Ferraz T (2009) Headache associated with pituitary tumors. J Headache Pain 10(1):15–20CrossRefPubMed Gondim JA, de Almeida JPC, de Albuquerque LAF, Schops M, Gomes É, Ferraz T (2009) Headache associated with pituitary tumors. J Headache Pain 10(1):15–20CrossRefPubMed
19.
go back to reference Wolf A, Goncalves S, Salehi F, Bird J, Cooper P, Uum SV, Lee DH, Rotenberg BW, Duggal N (2016) Quantitative evaluation of headache severity before and after endoscopic transsphenoidal surgery for pituitary adenoma. J Neurosurg 124(6):1627CrossRefPubMed Wolf A, Goncalves S, Salehi F, Bird J, Cooper P, Uum SV, Lee DH, Rotenberg BW, Duggal N (2016) Quantitative evaluation of headache severity before and after endoscopic transsphenoidal surgery for pituitary adenoma. J Neurosurg 124(6):1627CrossRefPubMed
20.
go back to reference Cain MR, Arkilo D, Linabery AM, Kharbanda AB (2018) Emergency department use of neuroimaging in children and adolescents presenting with headache. J Pediatr 201:196–201CrossRefPubMed Cain MR, Arkilo D, Linabery AM, Kharbanda AB (2018) Emergency department use of neuroimaging in children and adolescents presenting with headache. J Pediatr 201:196–201CrossRefPubMed
21.
go back to reference Elster AD, Chen MY, Williams DW III, Key LL (1990) Pituitary gland: MR imaging of physiologic hypertrophy in adolescence. Radiology 174(3 Pt 1):681–685CrossRefPubMed Elster AD, Chen MY, Williams DW III, Key LL (1990) Pituitary gland: MR imaging of physiologic hypertrophy in adolescence. Radiology 174(3 Pt 1):681–685CrossRefPubMed
22.
go back to reference Tsunoda A, Okuda O, Sato K (1997) MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climacterium. Am J Neuroradiol 18(3):551–554PubMed Tsunoda A, Okuda O, Sato K (1997) MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climacterium. Am J Neuroradiol 18(3):551–554PubMed
23.
go back to reference Vasilev V, Rostomyan L, Daly AF, Potorac I, Zacharieva S, Bonneville JF, Beckers A (2016) Management of endocrine disease: pituitary ‘incidentaloma’: neuroradiological assessment and differential diagnosis. Eur J Endocrinol 175(4):R171–R184CrossRefPubMed Vasilev V, Rostomyan L, Daly AF, Potorac I, Zacharieva S, Bonneville JF, Beckers A (2016) Management of endocrine disease: pituitary ‘incidentaloma’: neuroradiological assessment and differential diagnosis. Eur J Endocrinol 175(4):R171–R184CrossRefPubMed
24.
go back to reference Chanson P, Daujat F, Young J, Bellucci A, Kujas M, Doyon D, Schaison G (2001) Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: a follow-up study. J Clin Endocrinol Metabol 86(7):3009–3015CrossRef Chanson P, Daujat F, Young J, Bellucci A, Kujas M, Doyon D, Schaison G (2001) Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: a follow-up study. J Clin Endocrinol Metabol 86(7):3009–3015CrossRef
25.
go back to reference Al-Holou WN, Yew AY, Boomsaad ZE, Garton HJ, Muraszko KM, Maher CO (2010) Prevalence and natural history of arachnoid cysts in children. J Neurosurg Pediatr 5(6):578–585CrossRefPubMed Al-Holou WN, Yew AY, Boomsaad ZE, Garton HJ, Muraszko KM, Maher CO (2010) Prevalence and natural history of arachnoid cysts in children. J Neurosurg Pediatr 5(6):578–585CrossRefPubMed
26.
go back to reference Fernandez-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Perez L, de Leon-Lovaton PG, Erwin PJ (2011) Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab 96(4):905–912CrossRefPubMed Fernandez-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Perez L, de Leon-Lovaton PG, Erwin PJ (2011) Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab 96(4):905–912CrossRefPubMed
27.
go back to reference Rousseau-Nepton I, Kaduri S, Garfield N, Krishnamoorthy P (2014) Hypothalamic hamartoma associated with central precocious puberty and growth hormone deficiency. J Pediatr Endocrinol Metab 27(1–2):117–121PubMed Rousseau-Nepton I, Kaduri S, Garfield N, Krishnamoorthy P (2014) Hypothalamic hamartoma associated with central precocious puberty and growth hormone deficiency. J Pediatr Endocrinol Metab 27(1–2):117–121PubMed
28.
go back to reference Martin DD, Seeger U, Ranke MB, Grodd W (2003) MR imaging and spectroscopy of a tuber cinereum hamartoma in a patient with growth hormone deficiency and hypogonadotropic hypogonadism. Am J Neuroradiol 24(6):1177–1180PubMed Martin DD, Seeger U, Ranke MB, Grodd W (2003) MR imaging and spectroscopy of a tuber cinereum hamartoma in a patient with growth hormone deficiency and hypogonadotropic hypogonadism. Am J Neuroradiol 24(6):1177–1180PubMed
29.
go back to reference Maghnie M, Lindberg A, Koltowska-Haggstrom M, Ranke MB (2013) Magnetic resonance imaging of CNS in 15,043 children with GH deficiency in KIGS (Pfizer International Growth Database). Eur J Endocrinol 168(2):211–217CrossRefPubMed Maghnie M, Lindberg A, Koltowska-Haggstrom M, Ranke MB (2013) Magnetic resonance imaging of CNS in 15,043 children with GH deficiency in KIGS (Pfizer International Growth Database). Eur J Endocrinol 168(2):211–217CrossRefPubMed
30.
go back to reference Pedicelli S, Alessio P, Scire G, Cappa M, Cianfarani S (2014) Routine screening by brain magnetic resonance imaging is not indicated in every girl with onset of puberty between the ages of 6 and 8 years. J Clin Endocrinol Metab 99(12):4455–4461CrossRefPubMed Pedicelli S, Alessio P, Scire G, Cappa M, Cianfarani S (2014) Routine screening by brain magnetic resonance imaging is not indicated in every girl with onset of puberty between the ages of 6 and 8 years. J Clin Endocrinol Metab 99(12):4455–4461CrossRefPubMed
Metadata
Title
Pituitary incidentalomas in paediatric age are different from those described in adulthood
Authors
Pedro Souteiro
Rúben Maia
Rita Santos-Silva
Rita Figueiredo
Carla Costa
Sandra Belo
Cíntia Castro-Correia
Davide Carvalho
Manuel Fontoura
Publication date
01-04-2019
Publisher
Springer US
Published in
Pituitary / Issue 2/2019
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-019-00940-4

Other articles of this Issue 2/2019

Pituitary 2/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.